ATE178065T1 - Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten - Google Patents
Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonistenInfo
- Publication number
- ATE178065T1 ATE178065T1 AT93911925T AT93911925T ATE178065T1 AT E178065 T1 ATE178065 T1 AT E178065T1 AT 93911925 T AT93911925 T AT 93911925T AT 93911925 T AT93911925 T AT 93911925T AT E178065 T1 ATE178065 T1 AT E178065T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- receptor agonists
- triazole derivatives
- condensed imidazole
- date nov
- Prior art date
Links
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 1
- 229940024986 topical antifungal imidazole and triazole derivative Drugs 0.000 title 1
- 239000000556 agonist Substances 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929210400A GB9210400D0 (en) | 1992-05-15 | 1992-05-15 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178065T1 true ATE178065T1 (de) | 1999-04-15 |
Family
ID=10715527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93911925T ATE178065T1 (de) | 1992-05-15 | 1993-05-06 | Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5514682A (de) |
| EP (1) | EP0640085B1 (de) |
| JP (1) | JP3283260B2 (de) |
| AT (1) | ATE178065T1 (de) |
| AU (1) | AU671836B2 (de) |
| CA (1) | CA2134986A1 (de) |
| DE (1) | DE69324140T2 (de) |
| ES (1) | ES2128427T3 (de) |
| GB (1) | GB9210400D0 (de) |
| WO (1) | WO1993023396A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| TW251284B (de) * | 1992-11-02 | 1995-07-11 | Pfizer | |
| AU686654B2 (en) * | 1993-08-31 | 1998-02-12 | Pfizer Inc. | 5-arylindole derivatives |
| NZ276172A (en) * | 1994-02-10 | 1998-02-26 | Pfizer | 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists, 5-(hetero)arylaminoindole intermediates |
| GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| US5484763A (en) * | 1995-02-10 | 1996-01-16 | American Cyanamid Company | Substituted benzisoxazole and benzisothiazole herbicidal agents |
| JP2002507996A (ja) | 1997-07-03 | 2002-03-12 | デュポン ファーマシューティカルズ カンパニー | 神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類 |
| US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US6465484B1 (en) * | 1997-09-26 | 2002-10-15 | Merck & Co., Inc. | Angiogenesis inhibitors |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
| CA2341409A1 (en) * | 1998-08-31 | 2000-03-09 | Merck And Co., Inc. | Novel angiogenesis inhibitors |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| BR0312175A (pt) | 2002-06-21 | 2005-04-05 | Suven Life Sciences Ltd | Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso |
| ES2297216T3 (es) | 2002-06-21 | 2008-05-01 | Suven Life Sciences Limited | Indoles tetraciclicos arilsulfonil que tienen afinidad con el receptor de la serotonina. |
| US7507835B2 (en) | 2002-11-28 | 2009-03-24 | Suven Life Sciences Ltd. | N-arylsulfonyl-3-aminoalkoxyindoles |
| ATE401307T1 (de) | 2002-11-28 | 2008-08-15 | Suven Life Sciences Ltd | N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| JP4571507B2 (ja) | 2002-12-18 | 2010-10-27 | スベン ライフ サイエンシズ リミティド | セロトニン受容体親和性を有する四環系3−置換インドール |
| EP1724271A4 (de) * | 2004-02-26 | 2013-01-23 | Kyowa Hakko Kirin Co Ltd | Präventives und/oder therapeutisches mittel gegen neutrophile entzündungskrankheit |
| KR101594002B1 (ko) | 2010-10-06 | 2016-02-15 | 글락소스미스클라인 엘엘씨 | Pi3 키나제 억제제로서의 벤즈이미다졸 유도체 |
| BR122023023802A2 (pt) * | 2015-04-29 | 2023-12-26 | Janssen Pharmaceutica Nv | Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| HU225055B1 (en) * | 1990-10-15 | 2006-05-29 | Pfizer | Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds |
| CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
| TW251284B (de) * | 1992-11-02 | 1995-07-11 | Pfizer |
-
1992
- 1992-05-15 GB GB929210400A patent/GB9210400D0/en active Pending
-
1993
- 1993-05-06 EP EP93911925A patent/EP0640085B1/de not_active Expired - Lifetime
- 1993-05-06 US US08/335,800 patent/US5514682A/en not_active Expired - Fee Related
- 1993-05-06 AU AU42697/93A patent/AU671836B2/en not_active Ceased
- 1993-05-06 WO PCT/GB1993/000936 patent/WO1993023396A1/en not_active Ceased
- 1993-05-06 ES ES93911925T patent/ES2128427T3/es not_active Expired - Lifetime
- 1993-05-06 AT AT93911925T patent/ATE178065T1/de not_active IP Right Cessation
- 1993-05-06 CA CA002134986A patent/CA2134986A1/en not_active Abandoned
- 1993-05-06 JP JP51997193A patent/JP3283260B2/ja not_active Expired - Fee Related
- 1993-05-06 DE DE69324140T patent/DE69324140T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993023396A1 (en) | 1993-11-25 |
| EP0640085B1 (de) | 1999-03-24 |
| JP3283260B2 (ja) | 2002-05-20 |
| AU671836B2 (en) | 1996-09-12 |
| EP0640085A1 (de) | 1995-03-01 |
| AU4269793A (en) | 1993-12-13 |
| ES2128427T3 (es) | 1999-05-16 |
| US5514682A (en) | 1996-05-07 |
| DE69324140T2 (de) | 1999-10-28 |
| JPH07506825A (ja) | 1995-07-27 |
| DE69324140D1 (de) | 1999-04-29 |
| GB9210400D0 (en) | 1992-07-01 |
| CA2134986A1 (en) | 1993-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69324140D1 (de) | Kondensierte imidazol- und triazolderivate als 5-hta rezeptoragonisten | |
| ATE205202T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| ATE144773T1 (de) | Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne | |
| DE69331190D1 (de) | Überbrückte azabicyclische derivate als substanz p antagonisten | |
| ES2121193T3 (es) | Derivados de bencimidazoles. | |
| ATE183504T1 (de) | Piperazinderivate als 5-ht rezeptor antagonisten | |
| ATE171445T1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
| HU9300618D0 (en) | Imidazole derivatives containing biphenyl-sulfonyl-urea side chain or biphenyl-sulfonyl-urethane one as well as method for producing them and their utilization | |
| ATE250598T1 (de) | 5-(2-imidazolinylamino)benzimidazol derivate, deren herstellung und deren verwendung als alpha- 2-adrenoceptor agonisten | |
| DE59510635D1 (de) | Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden | |
| BR9910621A (pt) | Novos compostos de imidazol 2-alquil substituìdos | |
| CO4950530A1 (es) | Agonistas de receptores 5-ht, y metoclopramida para el tratamiento de la migrana | |
| DE69419917D1 (de) | Indazolderivate | |
| ATE177096T1 (de) | 4-substituierte 1,2,4-triazolderivate | |
| DE69301357D1 (de) | Indol derivate als "5-ht1-like" agonisten | |
| DE69329645D1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| ATE164376T1 (de) | Indol derivate als steroid 5 alpha-reductase inhibitoren | |
| DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| NO952427D0 (no) | Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5 | |
| MY108739A (en) | Imidazole, triazole and tetrazole derivatives | |
| KR970042548A (ko) | 이미다조 피리딘 유도체,이의 제조방법 및 이를 함유한 약제학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |